Mark R. Rigby

Pediatrics

705 Riley Hospital Dr
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.

Journal: The lancet. Diabetes & endocrinology

Published: June 18, 2023

Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders.

Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders.

Journal: Diabetes care

Published: May 12, 2022

Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.

Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis.

Journal: JCI insight

Published: April 11, 2022

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.

Journal: The New England journal of medicine

Published: November 18, 2020

Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.

Journal: Clinical therapeutics

Published: March 18, 2016

Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes.

Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes.

Journal: Diabetes care

Published: September 22, 2015

Targeting memory T cells in type 1 diabetes.

Targeting memory T cells in type 1 diabetes.

Journal: Current diabetes reports

Published: September 16, 2015

Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.

Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.

Journal: Clinical transplantation

Published: August 14, 2015

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.

Journal: The Journal of clinical investigation

Published: March 03, 2015

The Incidence of Ventilator-Associated Infections in Children Determined Using Bronchoalveolar Lavage.

The Incidence of Ventilator-Associated Infections in Children Determined Using Bronchoalveolar Lavage.

Journal: Global pediatric health

Published: January 01, 2015

Propofol-Based Procedural Sedation with or without Low-Dose Ketamine in Children.

Propofol-Based Procedural Sedation with or without Low-Dose Ketamine in Children.

Journal: Journal of pediatric intensive care

Published: November 17, 2014

Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children.

Successful use of intravenous dexmedetomidine for magnetic resonance imaging sedation in autistic children.

Journal: Southern medical journal

Published: September 05, 2014

Showing 1-12 of 26

Last Updated: 09/26/2026